Skip to main content
SpringerLink
Log in

Drug–Nutrient Interactions

  • Chapter
  • First Online:
Geriatric Gastroenterology

Abstract

Drug–nutrient interactions (DNIs) are on the increase in older adults due to high prevalence of polypharmacy, which presents an opportunity for drug interactions with nutrients. The impact and burden of DNIs in older adults are many, including morbidity, hospitalizations, and mortality. DNIs are contributary to adverse drug events. DNIs occur among a wide range of therapeutic classes. The risk factors contributing to DNIs, types of interactions, consequences, and examples of commonly used medications and herbal preparations and their interactions with nutrients are presented. Awareness of DNIs and proper drug selection offers opportunity for diagnosis and prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chan LN. Drug nutrient interactions in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2002;5:327–32.

    Article  PubMed  Google Scholar 

  2. Lourenco R. Enteral feeding: drug/nutrient interaction. Clin Nutr. 2001;20(2):187–93.

    Article  PubMed  CAS  Google Scholar 

  3. Chan LN. Drug-nutrient interactions in transplant recipients. J Parenter Enteral Nutr. 2001;25(3):132–41.

    Article  CAS  Google Scholar 

  4. Ward LS. The difficult patient: drug interactions and the influence of concomitant diseases on the treatment of hypothyroidism. Arq Bras Endocrinol Metabol. 2010;54(5):435–42.

    Article  PubMed  Google Scholar 

  5. Ogawa R, Echizen H. Drug-drug interaction profiles of proton pump inhibitors. Clin Pharmacokinet. 2010;49(8):509–33.

    Article  PubMed  CAS  Google Scholar 

  6. Hata M, Hayasaka M, Sezai A, et al. Proton pump inhibitors may increase the risk of delayed bleeding complications after open heart surgery if used concomitantly with warfarin. Thorac Cardiovasc Surg. 2008;56(05):274–7.

    Article  PubMed  CAS  Google Scholar 

  7. Johnstone J, Nerenberg K, Loeb M. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia. Aliment Pharmacol Ther. 2010;31(11):1165–77.

    Article  PubMed  CAS  Google Scholar 

  8. Zarowitz BJ. Pharmacologic consideration of commonly used gastrointestinal drugs in the elderly. Gastroenterol Clin North Am. 2009;38(3):547–62.

    Article  PubMed  Google Scholar 

  9. Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008;9(3):162–7.

    Article  PubMed  CAS  Google Scholar 

  10. http://www.chiro.org/nutrition/ABSTRACTS/Nutrient_Depletion.shtml. Accessed 3 Jan 2011.

  11. McLean AJ. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163–84.

    Article  PubMed  CAS  Google Scholar 

  12. McCabe BJ. Prevention of food-drug interactions with special emphasis on older adults. Curr Opin Clin Nutr Metab Care. 2004;7:21–6.

    Article  PubMed  Google Scholar 

  13. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(9582):185–91.

    Article  PubMed  CAS  Google Scholar 

  14. Utermohlen V. Nutrient–drug interactions. Encyclopedia of Food and Culture. 2003. http://www.encyclopedia.com/doc/1G2-3403400440.html. Accessed 23 Jan 2011.

  15. Sorenson JM. Herb-drug, food-drug, nutrient-drug and drug-drug interactions: mechanisms involved and their medical implications. J Altern Complement Med. 2002;8(3):293–308.

    Article  Google Scholar 

  16. Dharmarajan TS, Pitchumoni CS, Kokkat AJ. The aging gut. Pract Gastroenterol. 2001;25:15–27.

    Google Scholar 

  17. Akamine D, Filho MK, Peres CM. Drug nutrient interactions in elderly people. Curr Opin Clin Nutr Metab Care. 2007;10:304–10.

    Article  PubMed  Google Scholar 

  18. Armbrecht HJ, Boltz MA, Kumar VB. Intestinal plasma membrane calcium pump protein and its induction by 1,25 (OH)2D3 decrease with age. Am J Physiol Gastrointest Liver Physiol. 1999;277:G41–7.

    CAS  Google Scholar 

  19. Toyoshima M, Inada M, Kameyama M. Effects of aging on intracellular transport of vitamin B12 (B12) in rat enterocytes. J Nutr Sci Vitaminol (Tokyo). 1983;29(1):1–10.

    Article  CAS  Google Scholar 

  20. Custodio J, Wu C, Benet L. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv Drug Deliv Rev. 2008;60(6):717–33.

    Article  PubMed  CAS  Google Scholar 

  21. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38(8):843–53.

    Article  PubMed  CAS  Google Scholar 

  22. Genser D. Food and drug interaction: consequences for the nutrition/health status. Ann Nutr Metab. 2008;52(1):29–32.

    Article  PubMed  CAS  Google Scholar 

  23. Alemdaroglu NC, Dietz U, Wolffram S, Spahn-Langguth H, Langguth P. Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm Drug Dispos. 2008;29(6):335–48.

    Article  PubMed  CAS  Google Scholar 

  24. Simon Z. The effect of milk components, especially of casein, on the bioavailability of ciprofloxacin tablets cannot be evaluated by dissolution testing. J Pharm Biomed Anal. 2010;53(3):819.

    Article  PubMed  CAS  Google Scholar 

  25. De Lemos ML, Hamata L, Jennings S, Leduc T. Interaction between mercaptopurine and milk. J Oncol Pharm Pract. 2007;13(4):237–40.

    Article  PubMed  Google Scholar 

  26. Mulligan GB, Licata A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010;25(4):928–30.

    Article  PubMed  CAS  Google Scholar 

  27. Schmidt LE, Dalhoff K. Food-drug interactions. Drugs. 2002;62(10):1481–502.

    Article  PubMed  CAS  Google Scholar 

  28. Gauthier I, Malone M. Drug-food interactions in hospitalised patients. Methods of prevention. Drug Saf. 1998;18(6):383–93.

    Article  PubMed  CAS  Google Scholar 

  29. Lee RD, Vakily M, Mulford D, Wu J, Atkinson SN. Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor–evidence for dosing flexibility. Aliment Pharmacol Ther. 2009;29(8):824–33.

    Article  PubMed  CAS  Google Scholar 

  30. Gregory C. Drug and enteral feed interactions. J Hum Nutr Diet. 2006;19(3):237–9.

    Article  PubMed  CAS  Google Scholar 

  31. Kim T-E, Kim B-H, Kim J-R, et al. Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction. Br J Clin Pharmacol. 2009;68(1):43–6.

    Article  PubMed  CAS  Google Scholar 

  32. Khosravan R, Grabowski B, Wu J-T, Joseph-Ridge N, Vernillet L. Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects. Br J Clin Pharmacol. 2008;65(3):355–63.

    Article  PubMed  CAS  Google Scholar 

  33. Fernandez R, Phillips SF. Components of fiber bind iron in vitro. Am J Clin Nutr. 1982;35(1):100–6.

    PubMed  CAS  Google Scholar 

  34. Floren CH, Nilsson A. Binding of bile salts to fibre-enriched wheat fibre. Scand J Gastroenterol Suppl. 1987;129:192–9.

    Article  PubMed  CAS  Google Scholar 

  35. Heaney RP, Weaver CM. Effect of psyllium on absorption of co-ingested calcium. J Am Geriatr Soc. 1995;43(3):261–3.

    PubMed  CAS  Google Scholar 

  36. Lentz KA. Current methods for predicting human food effect. AAPS J. 2008;10(2):282–8.

    Article  PubMed  CAS  Google Scholar 

  37. Pelton R, LaValle JB, Hawkins EB, Krinsky DL. Drug-induced nutrient depletion handbook: 1999–2000. Hudson: Lexi-comp; 1999.

    Google Scholar 

  38. Mason P. Important drug–nutrient interactions. Proc Nutr Soc. 2010;69(04):551–7.

    Article  PubMed  Google Scholar 

  39. Henley E. Sorbitol-based elixirs, diarrhea and enteral tube feeding. Am Fam Physician. 1997;55(6):2084; 2086.

    Google Scholar 

  40. Abad MJ, Bedoya LM, Bermejo P. An update on drug interactions with the herbal medicine Ginkgo biloba. Curr Drug Metab. 2010;11(2):171–81.

    Article  PubMed  CAS  Google Scholar 

  41. Bressler R. Herb-drug interactions: interactions between ginseng and prescription medications. Geriatrics. 2005;60(8):16–7.

    PubMed  Google Scholar 

  42. Bressler R. Herb-drug interactions. Interactions between saw palmetto and prescription medications. Geriatrics. 2005;60(11):32; 34.

    Google Scholar 

  43. Wittkowsky AK. Dietary supplements, herbs and oral anticoagulants: the nature of the evidence. J Thromb Thrombolysis. 2008;25(1):72–7.

    Article  PubMed  CAS  Google Scholar 

  44. Ansell J, McDonough M, Zhao Y, Harmatz JS, Greenblatt DJ. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. J Clin Pharmacol. 2009;49(7):824–30.

    Article  PubMed  CAS  Google Scholar 

  45. Hamann GL, Campbell JD, George CM. Warfarin-cranberry juice interaction. Ann Pharmacother. 2011;45(3):e17.

    Article  PubMed  Google Scholar 

  46. Dharmarajan L, Dharmarajan TS. Prescribing warfarin appropriately to meet Patient Safety Goals. Am Health Drug Benefits. 2008;1(6):26–32.

    Google Scholar 

  47. Moore AA, Blow FC, Hoffing M, et al. Primary care-based intervention to reduce at-risk drinking in older adults: a randomized controlled trial. Addiction. 2011;106(1):111–20.

    Article  PubMed  Google Scholar 

  48. Hamid A, Kaur J. Long-term alcohol ingestion alters the folate-binding kinetics in intestinal brush border membrane in experimental alcoholism. Alcohol. 2007;41(6):441–6.

    Article  PubMed  CAS  Google Scholar 

  49. Hamid A, Wani NA, Kaur J. New perspectives on folate transport in relation to alcoholism-induced folate malabsorption - association with epigenome stability and cancer development. FEBS J. 2009;276(8):2175–91.

    Article  PubMed  CAS  Google Scholar 

  50. Gilbert RM. Caffeine consumption. Prog Clin Biol Res. 1984;158:185–213.

    PubMed  CAS  Google Scholar 

  51. Nehlig A. Are we dependent upon coffee and caffeine a review on human and animal data. Neurosci Biobehav Rev. 1999;23:563–76.

    Article  PubMed  CAS  Google Scholar 

  52. Rapuri P, Gallagher J, Nawaz Z. Caffeine decreases vitamin D receptor protein expression and 1,25(OH)2D3 stimulated alkaline phosphatase activity in human osteoblast cells. J Steroid Biochem Mol Biol. 2007;103(3–5):368–71.

    Article  PubMed  CAS  Google Scholar 

  53. Korpelainen R, Korpelainen J, Heikkinen J, et al. Lifestyle factors are associated with osteoporosis in lean women but not in normal and overweight women: a population-based cohort study of 1222 women. Osteoporos Int. 2003;14(1):34–43.

    Article  PubMed  CAS  Google Scholar 

  54. Hallström H, Wolk A, Glynn A, Michaëlsson K. Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int. 2006;17(7):1055–64.

    Article  PubMed  Google Scholar 

  55. Eadie MJ. Clinically significant drug interactions with agents specific for migraine attacks. CNS Drugs. 2001;15(2):105–18.

    Article  PubMed  CAS  Google Scholar 

  56. Jankiewicz K, Chroscinska-Krawczyk M, Blaszczyk B, Czuczwar SJ. Caffeine and antiepileptic drugs: experimental and clinical data. Przegl Lek. 2007;64(11):965–7.

    PubMed  Google Scholar 

  57. Cysneiros RM, Farkas D, Harmatz JS, von Moltke LL, Greenblatt DJ. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. Clin Pharmacol Ther. 2007;82(1):54–62.

    Article  PubMed  CAS  Google Scholar 

  58. Hegarty VM, May HM, Khaw K. Tea drinking and bone mineral density in older women. Am J Clin Nutr. 2000;71:1003–7.

    PubMed  CAS  Google Scholar 

  59. Chen Z. Habitual tea consumption and risk of osteoporosis: a prospective study in the women’s health initiative observational cohort. Am J Epidemiol. 2003;158(8):772–81.

    Article  PubMed  CAS  Google Scholar 

  60. Devine A, Hodgson JM, Dick IM, Prince RL. Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr. 2007;86:1243–7.

    PubMed  CAS  Google Scholar 

  61. Cooper M, Safran M, Eberhardt M. Caffeine consumption among adults on benzodiazepine therapy: United States 1988–1994. Psychol Rep. 2004;95(1):183–91.

    Article  PubMed  Google Scholar 

  62. Houston MC. Nutrition and nutraceutical supplements in the treatment of hypertension. Expert Rev Cardiovasc Ther. 2010;8(6):821–33.

    Article  PubMed  CAS  Google Scholar 

  63. Brosen K. Differences in interactions of SSRIs. Int Clin Psychopharmacol. 1998;13 Suppl 5:S45–7.

    Article  PubMed  Google Scholar 

  64. Nathisuwan S, Dilokthornsakul P, Chaiyakunapruk N, et al. Assessing evidence of interaction between smoking and warfarin: a systematic review and meta-analysis. Chest. 2011;139(5):1130–9.

    Article  PubMed  Google Scholar 

  65. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999;36(6):425–38.

    Article  PubMed  CAS  Google Scholar 

  66. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007;64(18):1917–21.

    Article  PubMed  CAS  Google Scholar 

  67. Vitamin D. 2010. http://www.nlm.nih.gov/medlineplus/druginfo/natural/929.html. Accessed 27 Jan 2011.

  68. Dharmarajan TS, Norkus EP. Does long-term PPI use result in vitamin B12 deficiency in elderly individuals? Nat Clin Pract Gastroenterol Hepatol. 2008;5(11):604–5.

    Article  PubMed  CAS  Google Scholar 

  69. Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep. 2010;12(6):448–57.

    Article  PubMed  Google Scholar 

  70. Stover PJ. Vitamin B12 and older adults. Curr Opin Clin Nutr Metab Care. 2010;13(1):24–7.

    Article  PubMed  CAS  Google Scholar 

  71. Liu KW. Metformin-related vitamin B12 deficiency. Age Ageing. 2006;35(2):200–1.

    Article  PubMed  CAS  Google Scholar 

  72. Ezra A, Hoffman A, Breuer E, et al. A peptide prodrug approach for improving bisphosphonate oral absorption. J Med Chem. 2000;43:3641–52.

    Article  PubMed  CAS  Google Scholar 

  73. Mitchell DY, Eusebio RA, Sacco-Gibson NA. Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers. J Clin Pharmacol. 2000;40(3):258–65.

    Article  PubMed  CAS  Google Scholar 

  74. Gertz BJ, Holland SD, Kline WF. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther. 1995;58(3):288–98.

    Article  PubMed  CAS  Google Scholar 

  75. Umland EM, Boyce EG. Risedronate a new oral bisphosphonate. Clin Ther. 2001;24(5):835–6.

    Google Scholar 

  76. Williams NT. Medication administration through enteral feeding tubes. Am J Health Syst Pharm. 2008;65(24):2347–57.

    Article  PubMed  CAS  Google Scholar 

  77. Beckwith MC, Feddema SS, Barton RG, Graves C. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hosp Pharm. 2004;39(3):225–37.

    Google Scholar 

  78. Brown RO, Dickerson RN. Drug nutrient interactions. Am J Manag Care. 2000;5(3):345–55.

    Google Scholar 

  79. Klang M, Graham D, McLymont V. Warfarin bioavailability with feeding tubes and enteral formula. J Parenter Enteral Nutr. 2010;34(3):300–4.

    Article  CAS  Google Scholar 

  80. Muramatsu RS, Litzinger MHJ, Fisher E, Takeshita J. Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia. Am J Geriatr Pharmacother. 2010;8(2):98–114.

    Article  PubMed  CAS  Google Scholar 

  81. Wohlt PD, Zheng L, Gunderson S, et al. Recommendations for the use of medications with continuous enteral nutrition. Am J Health Syst Pharm. 2009;66(16):1458–67.

    Article  PubMed  CAS  Google Scholar 

  82. Mirtallo JM. Complications associated with drug and nutrient interactions. J Infus Nurs. 2004;27(1):19–24.

    Article  PubMed  Google Scholar 

  83. Gardiner P, Graham R, Legedza ATR, et al. Factors associated with herbal therapy use by adults in the USA. Altern Ther Health Med. 2007;13:22–9.

    PubMed  Google Scholar 

  84. Bent S. Commonly used herbal medicines in the United States: a review. Am J Med. 2004;116(7):478–85.

    Article  PubMed  Google Scholar 

  85. Nowack R. Cytochrome P450 enzyme, and transport protein mediated herb–drug interactions in renal transplant patients: grapefruit juice, St John’s wort—and beyond! (review article). Nephrology. 2008;13(4):337–47.

    Article  PubMed  CAS  Google Scholar 

  86. Boobis A, Watelet J-B, Whomsley R, et al. Drug interactions. Drug Metab Rev. 2009;41(3):486–527.

    Article  PubMed  CAS  Google Scholar 

  87. Sica D. Interaction of grapefruit juice and calcium channel blockers. Am J Hypertens. 2006;19(7):768–73.

    Article  PubMed  CAS  Google Scholar 

  88. Dharmarajan TS, Pitchumoni CS. Drug-nutrient interactions in older adults. Pract Gastroenterol. 2002;26(4):37–55.

    Google Scholar 

  89. Tapaninen T, Neuvonen PJ, Niemi M. Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren. Clin Pharmacol Ther. 2010;88(3):339–42.

    Article  PubMed  CAS  Google Scholar 

  90. Lin C, Ke X, Ranade V, Somberg J. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Cardiology. 2008;110(3):145–52.

    Article  PubMed  CAS  Google Scholar 

  91. Hammerness P, Basch E, Ulbricht C, et al. St John’s wort a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics. 2003;44:271–82.

    Article  PubMed  CAS  Google Scholar 

  92. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. St John’s wort (hypericum perforatum) drug interactions and clinical outcomes. Br J Clin Pharmacol. 2002;54:349–56.

    Article  PubMed  CAS  Google Scholar 

  93. Han H-K. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opin Drug Metab Toxicol. 2011;7(6):721–9.

    Article  PubMed  CAS  Google Scholar 

  94. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s wort, ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 2002;136:42–53.

    PubMed  Google Scholar 

  95. Sanchez-Muniz FJ, Bastida S, Gutierrez-Garcia O, Carbajal A. Olive oil-diet improves the simvastatin effects with respect to sunflower oil-diet in men with increased cardiovascular risk: a preliminary study. Nutr Hosp. 2009;24(3):333–9.

    PubMed  CAS  Google Scholar 

  96. Ovesen L, Lyduch S, Idorn ML. The effect of a diet rich in brussels sprouts on warfarin pharmacokinetics. Eur J Clin Pharmacol. 1988;33:521–3.

    Article  Google Scholar 

  97. Deferme S, Mols R, Van Driessche W, Augustijns P. Apricot extract inhibits the P-gp-mediated efflux of talinolol. J Pharm Sci. 2002;91(12):2539–48.

    Article  PubMed  CAS  Google Scholar 

  98. Al-Ghazawi MA, Tutunji MS, AbuRuz SM. The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteers. Eur J Clin Pharmacol. 2010;66(2):159–63.

    Article  PubMed  CAS  Google Scholar 

  99. Houston MC. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis. 2010;4(3):165–83.

    Article  PubMed  CAS  Google Scholar 

  100. Pae C, Lim H, Han C, Neena A, Lee C, Patkar A. Selegiline transdermal system: current awareness and promise. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(6):1153–63.

    Article  PubMed  CAS  Google Scholar 

  101. Bush TM, Rayburn KS, HoUoway SW, et al. Adverse interactions between herbal and dietary substances and prescription medications a clinical survey. Altern Ther Health Med. 2007;13(2):30–5.

    PubMed  Google Scholar 

  102. Vaes LPJ, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother. 2000;34:1478–82.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Montefiore Medical Center (North Division), Bronx, NY, USA

    Srinivas Guptha Gunturu MD

  2. New York Medical College, Valhalla, NY, USA

    T. S. Dharmarajan MD, FACP, AGSF (Professor of Medicine, Associate Dean)

  3. Department of Medicine, Montefiore Medical Center (North Division), 600 East 233rd Street, Bronx, NY, 10466, USA

    T. S. Dharmarajan MD, FACP, AGSF (Vice Chairman)

  4. Division of Geriatrics, Montefiore Medical Center (North Division), 600 East 233rd Street, Bronx, NY, 10466, USA

    T. S. Dharmarajan MD, FACP, AGSF (Clinical Director)

  5. Geriatric Medicine Fellowship Program, Montefiore Medical Center (North Division), 600 East 233rd Street, Bronx, NY, 10466, USA

    T. S. Dharmarajan MD, FACP, AGSF (Program Director)

Authors
  1. Srinivas Guptha Gunturu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. S. Dharmarajan MD, FACP, AGSF
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. S. Dharmarajan MD, FACP, AGSF
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. S. Dharmarajan MD, FACP, AGSF
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. S. Dharmarajan MD, FACP, AGSF
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. S. Dharmarajan MD, FACP, AGSF .

Editor information

Editors and Affiliations

  1. Hospital, Department of Medicine, Saint Peter’s University, 254 Easton Ave, New Brunswick, 08901, New Jersey, USA

    C. S. Pitchumoni

  2. (North Division), Department of Medicine, Montefiore Medical Center, 600 East 233rd Street, Bronx, 10466, New York, USA

    T. S. Dharmarajan

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Gunturu, S.G., Dharmarajan, T.S., Dharmarajan, T.S., Dharmarajan, T.S., Dharmarajan, T.S. (2012). Drug–Nutrient Interactions. In: Pitchumoni, C., Dharmarajan, T. (eds) Geriatric Gastroenterology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1623-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1623-5_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1622-8

  • Online ISBN: 978-1-4419-1623-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation